Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of ...

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain.Program ...

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) ...

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker ...

Expanding the Clinical Value of Nociscan Beyond Surgical Decision Support ...

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World ...

Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience group Adds to growing body of real-world evidence with ...
The Manila Times

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion, Inc., ('Aclarion” or the 'Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is ...